Mercury Laboratories Limited (BOM:538964)
755.00
-5.00 (-0.66%)
At close: Oct 16, 2026
Mercury Laboratories Revenue
Mercury Laboratories had revenue of 159.63M INR in the quarter ending June 30, 2026, a decrease of -11.98%. This brings the company's revenue in the last twelve months to 737.65M, down -3.65% year-over-year. In the fiscal year ending March 31, 2026, Mercury Laboratories had annual revenue of 759.37M with 1.11% growth. That makes Mercury Laboratories the 38,343rd largest company in the world by revenue and 3,444th in India.
Revenue (ttm)
737.65M
Revenue Growth
-3.65%
P/S Ratio
1.23
Revenue / Employee
1.45M
Employees
510
Market Cap
906.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 759.37M | 8.36M | 1.11% |
| Mar 31, 2025 | 751.01M | -4.58M | -0.61% |
| Mar 31, 2024 | 755.59M | 2.25M | 0.30% |
| Mar 31, 2023 | 753.34M | 174.10M | 30.06% |
| Mar 31, 2022 | 579.24M | -106.78M | -15.56% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Concord Drugs | 860.69M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Shelter Pharma | 731.34M |
| Amwill Health Care | 454.92M |
| Cian Healthcare | 282.99M |
| Asston Pharmaceuticals | 254.69M |